TScan Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGM:TCRX Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
13 Dec 24	BuyUS$385,769	Lynx1 Capital Management LP	Company	131,800	US$3.01
15 Nov 24	BuyUS$4,114	Lynx1 Capital Management LP	Company	947	US$4.34
23 Sep 24	BuyUS$26,450	Barbara Klencke	Individual	5,000	US$5.29
26 Aug 24	BuyUS$56,100	Barbara Klencke	Individual	10,000	US$5.69
23 Aug 24	SellUS$43,361	Zoran Zdraveski	Individual	7,500	US$5.78

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of TCRX?
Owner Type	Number of Shares	Ownership Percentage
Individual Insiders	434,915	0.77%
Private Companies	700,000	1.24%
General Public	6,298,382	11.1%
Hedge Funds	19,954,092	35.3%
Institutions	29,118,001	51.5%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 18.2%.

Top Shareholders

Top 25 shareholders own 83.47% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
12.5%	Baker Bros. Advisors LP	7,061,380	US$21.8m	0%	0.21%
9.48%	Lynx1 Capital Management LP	5,357,347	US$16.5m	2.54%	6.99%
8.85%	EcoR1 Capital, LLC	5,000,000	US$15.4m	0%	0.54%
8.2%	BlackRock, Inc.	4,632,876	US$14.3m	3.82%	no data
7.79%	Adage Capital Management, L.P.	4,400,000	US$13.6m	0%	0.02%
6.18%	BVF Partners L.P.	3,492,712	US$10.8m	16.8%	0.34%
4.15%	The Vanguard Group, Inc.	2,346,894	US$7.2m	10%	no data
3.69%	Propel Bio Management, LLC	2,087,139	US$6.4m	101%	6.21%
3.68%	Pitango Venture Capital	2,079,985	US$6.4m	0%	8.62%
2.2%	Deer Management Company, LLC	1,245,504	US$3.8m	0%	0.13%
1.91%	GV Management Company, LLC	1,077,080	US$3.3m	0%	0.23%
1.85%	Simplify Asset Management Inc.	1,046,916	US$3.2m	0%	0.22%
1.8%	Great Point Partners, LLC	1,016,375	US$3.1m	8.03%	1.2%
1.72%	Geode Capital Management, LLC	973,466	US$3.0m	8.1%	no data
1.52%	StemPoint Capital LP	860,951	US$2.7m	1.88%	0.9%
1.46%	Checkpoint Capital, LLC, Asset Management Arm	825,341	US$2.5m	0%	1.3%
1.34%	State Street Global Advisors, Inc.	756,499	US$2.3m	24.4%	no data
1.24%	K2 Healthventures Equity Trust LLC	700,000	US$2.2m	-68%	no data
1.18%	Dean Capital Investments Management, LLC	665,563	US$2.1m	0%	1.37%
0.66%	abrdn plc	371,655	US$1.1m	27.2%	no data
0.57%	Northern Trust Global Investments	324,276	US$1.0m	233%	no data
0.53%	Morgan Stanley, Investment Banking and Brokerage Investments	299,002	US$922.4k	25.6%	no data
0.36%	Tocqueville Asset Management LP	205,730	US$634.7k	-1.95%	0.01%
0.3%	David Southwell	171,569	US$529.3k	0%	no data
0.29%	Marshall Wace LLP	165,160	US$509.5k	-46.3%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/01/03 23:43
End of Day Share Price	2025/01/03 00:00
Earnings	2024/09/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

TScan Therapeutics, Inc. is covered by 9 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Peter Lawson	Barclays
Justin Zelin	BTIG
Andrew Fein	H.C. Wainwright & Co.